Lv11
34 积分 2026-09-16 加入
Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 3 trial (SLE-BRAVE-I)
2小时前
已完结
Time of day-dependent immune dynamics are associated with disease severity and therapeutic response in psoriasis
14天前
已完结
Immune Circuit Rewiring by HDAC Inhibition Enables Response to Dual Checkpoint Blockade in Metastatic Breast Cancer
1个月前
已完结
皖公网安备34019202002308
